Please login to the form below

Not currently logged in
Email:
Password:

Lexington Communications promotes Joanne Bullen

She takes on leadership of its UK and international healthcare practice

Lexington Communications Joanne BullenLondon-based agency Lexington Communications has appointed Joanne Bullen to lead its UK and international health practice.

She currently serves as director of international operations at Lexington Health and will take on the UK healthcare practice position when the current director, Jessica Fine, moves to MSD in April.

Mike Craven, a partner at Lexington Communications, said: “Jo Bullen and Jess Fine have worked together over the last few years to create a market-leading health offer.

“Jo, who is one of our most experienced directors, will now lead both the UK and international health business.”

Bullen brings over 20 years of strategic counsel expertise to the role, and prior to joining Lexington Health served as a senior director at US-based PR firm APCO Worldwide.

She said: “I believe the team is one of the best in the market, partnering with some of the most exciting healthcare companies around the world.

“I look forward to working with the excellent Lexington team in our London and Manchester offices to build on our success delivering first class, innovative and results-driven work for our clients.”

29th February 2016

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Star

We're passionate about helping our clients to make a real commercial impact. We achieve this through our unique approach to...

Latest intelligence

The 10-year Web Challenge
Understanding your users’ needs is more critical online today than ever. A site should mould itself around these insights, deliver those needs quickly, efficiently and with plenty of white space....
Downloadable Pack: Understanding Multiple Sclerosis
Inside this downloadable pack, you’ll find a wealth of exclusive information on the way multiple sclerosis is commonly treated today. As well as areas of continuous improvement for the industry....
Cutting through the noise
AstraZeneca looks to lead an R&D revolution as the company invests in CRISPR and functional genomics drug discovery...

Infographics